Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.929
Neutral
RSI(14)
42.656
Neutral
STOCH(KDJ)(9,3,3)
78.524
Buy
ATR(14)
1.652
Low Volatility
CCI(14)
43.259
Neutral
Williams %R
27.814
Buy
TRIX(12,20)
-0.428
Sell
StochRSI(14)
87.286
Overbought
Search
Medtronic PLC
MDTAdd to Watchlist
78.580USD
+0.430+0.55%
Market hours （ET）Quotes delayed by 15 min
100.74BMarket Cap
21.84P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Medtronic PLC
Currency: USD Updated: 2026-05-21Key Insights
Medtronic PLC's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 107.51.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Medtronic PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
48°C
Very Low
Very High
Positive
Medtronic PLC Highlights
StrengthsRisks
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 33.54B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 76.98%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 76.98%.
Undervalued
The company’s latest PE is 21.72, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.12B shares, decreasing 3.05% quarter-over-quarter.
Held by Scotia Canadian Dividend Fund
Star Investor Scotia Canadian Dividend Fund holds 118.91K shares of this stock.
Analyst Rating
Based on
33
analysts
Buy
Current Rating
107.510
Target Price
+39.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-21The current financial score of Medtronic PLC is 7.26, ranking 93 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 9.02B, representing a year-over-year increase of 8.74%, while its net profit experienced a year-over-year increase of 11.67%.
Score
Financials
7.26
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.26
Operational Efficiency
7.26
Growth Potential
7.26
Shareholder Returns
7.26
Medtronic PLC's Company Valuation
Currency: USD Updated: 2026-05-21The current valuation score of Medtronic PLC is 8.45, ranking 18 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 21.72, which is 49.29% below the recent high of 32.42 and 4.62% above the recent low of 20.72.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 44/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-21The current earnings forecast score of Medtronic PLC is 7.52, ranking 134 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 111.00, with a high of 125.00 and a low of 92.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
33
analysts
Buy
Current Rating
107.510
Target Price
+39.05%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
116
Total
6
Median
9
Average
Company name
Ratings
Analysts
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
Insulet Corp
PODD
28
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-21The current price momentum score of Medtronic PLC is 7.26, ranking 83 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 83.33 and the support level at 73.68, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
77.670
Buy
MA10
76.904
Buy
MA20
78.459
Buy
MA50
83.354
Sell
MA100
90.800
Sell
MA200
93.199
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-21The current institutional shareholding score of Medtronic PLC is 7.00, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 86.90%, representing a quarter-over-quarter decrease of 0.54%. The largest institutional shareholder is First Eagle Investment, holding a total of 9.86M shares, representing 0.77% of shares outstanding, with 0.39% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-21The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Medtronic PLC is 9.76, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.63. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.63
VaR
+2.23%
240-Day Maximum Drawdown
+29.25%
240-Day Volatility
+21.75%
Return
Best Daily Return
60 days
+3.06%
120 days
+3.06%
5 years
+4.69%
Worst Daily Return
60 days
-3.53%
120 days
-3.53%
5 years
-7.26%
Sharpe Ratio
60 days
-3.98
120 days
-2.99
5 years
-0.24
Risk Assessment
Maximum Drawdown
240 days
+29.25%
3 years
+29.25%
5 years
+48.64%
Return-to-Drawdown Ratio
240 days
-0.36
3 years
-0.11
5 years
-0.15
Skewness
240 days
+0.33
3 years
-0.24
5 years
-0.40
Volatility
Realised Volatility
240 days
+21.75%
5 years
+22.80%
Standardised True Range
240 days
+2.26%
5 years
+2.28%
Downside Risk-Adjusted Return
120 days
-484.15%
240 days
-484.15%
Maximum Daily Upside Volatility
60 days
+13.91%
Maximum Daily Downside Volatility
60 days
+15.28%
Liquidity
Average Turnover Rate
60 days
+0.69%
120 days
+0.64%
5 years
--
Turnover Deviation
20 days
+36.20%
60 days
+20.61%
120 days
+11.47%
Peer Comparison
Healthcare Equipment & Supplies
Medtronic PLC
MDT
7.71 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.74 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Illumina Inc
ILMN
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ICU Medical Inc
ICUI
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
